Kaufman & Broad S.A. (FRA:3GH)
Germany · Delayed Price · Currency is EUR 30.60
-0.50 (-1.61%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is December - November.
Millions EUR. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2016 - 2020 |
Net Income | 47.1 | 44.97 | 60.15 | 49.01 | 43.87 | 40.14 | Upgrade |
Depreciation & Amortization | 16.85 | 15.31 | 6.04 | 6.53 | 2.43 | 3.06 | Upgrade |
Other Amortization | 4.24 | 4.18 | 3.86 | - | 4.18 | 4.08 | Upgrade |
Loss (Gain) From Sale of Investments | 0 | -0.12 | -0.09 | -0.13 | -0.05 | 0.07 | Upgrade |
Loss (Gain) on Equity Investments | 3.2 | 0.22 | -0.85 | -2.02 | -1.86 | -2.32 | Upgrade |
Other Operating Activities | 20.56 | -7.38 | 60.35 | 24.72 | 51.85 | 48.81 | Upgrade |
Change in Accounts Receivable | 2.07 | 62.75 | - | - | - | - | Upgrade |
Change in Inventory | 75.03 | 46.01 | - | - | - | - | Upgrade |
Change in Accounts Payable | 12.81 | -3.12 | - | - | - | - | Upgrade |
Change in Other Net Operating Assets | 63.79 | 124.56 | 245.3 | -58.38 | -8.12 | 6.99 | Upgrade |
Operating Cash Flow | 245.66 | 287.38 | 374.75 | 19.73 | 92.29 | 100.82 | Upgrade |
Operating Cash Flow Growth | 10.21% | -23.31% | 1799.88% | -78.63% | -8.47% | 15.30% | Upgrade |
Capital Expenditures | -5.1 | -5.15 | -5.75 | -11.6 | -4.57 | -4.81 | Upgrade |
Cash Acquisitions | -0.45 | -0.17 | -0.1 | -0.13 | - | - | Upgrade |
Divestitures | - | - | - | - | - | 0.82 | Upgrade |
Sale (Purchase) of Real Estate | - | - | 0.35 | -7.92 | -12.45 | - | Upgrade |
Investment in Securities | -7.78 | -6.95 | -5.58 | -1.07 | -5.32 | -2.31 | Upgrade |
Investing Cash Flow | -13.34 | -12.27 | -11.08 | -20.72 | -22.33 | -6.3 | Upgrade |
Long-Term Debt Issued | - | - | - | 148.63 | - | - | Upgrade |
Long-Term Debt Repaid | - | -62.49 | -7.63 | -144.57 | -7.15 | -6.86 | Upgrade |
Net Debt Issued (Repaid) | -113.63 | -62.49 | -7.63 | 4.06 | -7.15 | -6.86 | Upgrade |
Issuance of Common Stock | 15.27 | 11.31 | 14.7 | 13.1 | 13.15 | - | Upgrade |
Repurchase of Common Stock | -15.29 | -11.51 | -47.72 | -30.62 | -27.96 | -18.39 | Upgrade |
Common Dividends Paid | -43.14 | -46.77 | -49.51 | -40.48 | -39.32 | -38.04 | Upgrade |
Other Financing Activities | -10.58 | -12.84 | -24.46 | -33.53 | -34.4 | -24.15 | Upgrade |
Financing Cash Flow | -167.37 | -122.3 | -114.62 | -87.47 | -95.69 | -87.43 | Upgrade |
Net Cash Flow | 64.96 | 152.82 | 249.05 | -88.46 | -25.73 | 7.09 | Upgrade |
Free Cash Flow | 240.56 | 282.24 | 369 | 8.12 | 87.72 | 96.01 | Upgrade |
Free Cash Flow Growth | 10.75% | -23.51% | 4442.10% | -90.74% | -8.64% | 18.00% | Upgrade |
Free Cash Flow Margin | 21.41% | 26.21% | 26.19% | 0.62% | 6.84% | 8.25% | Upgrade |
Free Cash Flow Per Share | 12.27 | 14.31 | 17.96 | 0.38 | 4.13 | 4.43 | Upgrade |
Cash Income Tax Paid | 10.81 | 37.46 | -4.63 | 36.41 | 7.48 | 2.26 | Upgrade |
Levered Free Cash Flow | 226.13 | 272.54 | 337.54 | -24.92 | 72.96 | 76.01 | Upgrade |
Unlevered Free Cash Flow | 229.39 | 276.32 | 341.7 | -20.65 | 76 | 79.59 | Upgrade |
Change in Net Working Capital | -162.67 | -213.75 | -271.18 | 79.53 | -11.09 | -27.53 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.